John Aballi - Net Worth and Insider Trading
John Aballi Net Worth
The estimated net worth of John Aballi is at least $1 Million dollars as of 2024-05-21. John Aballi is the President and CEO of Exagen Inc and owns about 641,189 shares of Exagen Inc (XGN) stock worth over $1 Million. Details can be seen in John Aballi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Aballi has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).
Transaction Summary of John Aballi
John Aballi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Aballi owns 1 companies in total, including Exagen Inc (XGN) .
Click here to see the complete history of John Aballi’s form 4 insider trades.
Insider Ownership Summary of John Aballi
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XGN | Exagen Inc | 2023-10-17 | director & President and CEO |
John Aballi Latest Holdings Summary
John Aballi currently owns a total of 1 stock. John Aballi owns 641,189 shares of Exagen Inc (XGN) as of May 16, 2024, with a value of $1 Million.
Latest Holdings of John Aballi
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XGN | Exagen Inc | 2024-05-16 | 641,189 | 1.87 | 1,199,023 |
Holding Weightings of John Aballi
John Aballi Form 4 Trading Tracker
According to the SEC Form 4 filings, John Aballi has made a total of 3 transactions in Exagen Inc (XGN) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Exagen Inc is the acquisition of 40,401 shares on May 16, 2024, which cost John Aballi around $77,570.
Insider Trading History of John Aballi
- 1
John Aballi Trading Performance
GuruFocus tracks the stock performance after each of John Aballi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Aballi is -5.06%. GuruFocus also compares John Aballi's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Aballi within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Aballi's insider trading performs compared to the benchmark.
Performance of John Aballi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.5 | | | | | |
| Relative Return to S&P 500(%) | -1.77 | | | | | |
John Aballi Ownership Network
John Aballi Owned Company Details
What does Exagen Inc do?
Who are the key executives at Exagen Inc?
John Aballi is the director & President and CEO of Exagen Inc. Other key executives at Exagen Inc include Chief Financial Officer Kamal Adawi , 10 percent owner Tullis Growth Fund Ii, L.p. , and Chief Operating Officer Mark Hazeltine .
Exagen Inc (XGN) Insider Trades Summary
Over the past 18 months, John Aballi made 3 insider transaction in Exagen Inc (XGN) with a net purchase of 96,582. Other recent insider transactions involving Exagen Inc (XGN) include a net sale of 25,343 shares made by Kamal Adawi , a net sale of 5,821 shares made by Mark Hazeltine , and a net purchase of 167 shares made by Tullis Growth Fund Ii, L.p. .
In summary, during the past 3 months, insiders sold 12,784 shares of Exagen Inc (XGN) in total and bought 40,401 shares, with a net purchase of 27,617 shares. During the past 18 months, 64,983 shares of Exagen Inc (XGN) were sold and 130,568 shares were bought by its insiders, resulting in a net purchase of 65,585 shares.
Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exagen Inc Insider Transactions
John Aballi Mailing Address
Above is the net worth, insider trading, and ownership report for John Aballi. You might contact John Aballi via mailing address: C/o Decipher Biosciences, Inc., 6925 Lusk Blvd, Suite 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
